Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0000905148-23-000919

Chief Medical Officer sold 2,000 shares at $55.48 ($110,952)

  • Chief Medical Officer acquired 2,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Garren Hideki · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-13 Exercise or conversion : show line 1 in the form 10b5-1 +2,000 $24.90 $49,800 2,000 D
2023-09-13 Sale : show line 2 in the form 10b5-1 −2,000 $55.48 $110,952 0 D
Open-market sales · 2,000 sh · avg $55.48 · $110,952

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-13 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −2,000 192,000 D
Loading xslF345X05/form4.xml…